Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database

被引：0
|
作者：
Megan C. Roberts
Dave P. Miller
Steven Shak
Valentina I. Petkov
机构：
[1] National Cancer Institute,
[2] Genomic Health Inc.,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词：
Breast cancer; Disease-specific survival; Lymph node-positive; Oncotype DX; Recurrence Score; SEER;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 310
页数：7
相关论文
共 50 条
  • [1] Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
    Roberts, Megan C.
    Miller, Dave P.
    Shak, Steven
    Petkov, Valentina I.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 303 - 310
  • [2] Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database
    Roberts, Megan
    Petkov, Valentina I.
    Miller, Dave P.
    Shak, Steven
    Howlader, Nadia
    Cronin, Kathleen
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Breast cancer specific survival in 38,568 patients with node negative hormone receptor positive invasive breast cancer and oncotype DX recurrence score results in the SEER database
    Shak, S.
    Petkov, V. I.
    Miller, D. P.
    Howlader, N.
    Gliner, N.
    Howe, W.
    Schussler, N.
    Cronin, K.
    Baehner, F. L.
    Penberthy, L.
    CANCER RESEARCH, 2016, 76
  • [4] Breast cancer specific mortality in patients with early-stage hormone receptor-positive invasive breast cancer and oncotype DX recurrence score results in the SEER database.
    Shak, Steven
    Petkov, Valentina
    Miller, Dave P.
    Howlader, Nadia
    Gliner, Nathan
    Howe, Will
    Schussler, Nicola C.
    Cronin, Kathleen
    Baehner, Frederick L.
    Penberthy, Lynne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [5] Breast cancer-specific survival in >4,600 patients with lymph node-positive (LN plus ) hormone receptor-positive (HR plus ) invasive breast cancer (BC) and 21-gene recurrence score® (RS) results in the SEER registries
    Miller, D. P.
    Roberts, M.
    Petkov, V. I.
    Shak, S.
    Howlader, N.
    Cronin, K.
    Penberthy, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Oncotype DX score in hormone receptor-positive/HER2-positive breast cancer: A SEER analysis.
    Qasrawi, Ayman
    Myint, Zin
    Alnimer, Yanal Mufeed
    Romond, Edward H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come
    Mittendorf, Elizabeth A.
    King, Tari A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1173 - 1175
  • [8] Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come
    Elizabeth A. Mittendorf
    Tari A. King
    Annals of Surgical Oncology, 2019, 26 : 1173 - 1175
  • [9] Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results
    Fried, Georgeta
    Moskovitz, Mor
    SPRINGERPLUS, 2014, 3 : 1 - 8
  • [10] Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer
    Li, Yunhai
    Yang, Dejuan
    Yin, Xuedong
    Zhang, Xiang
    Huang, Jiefeng
    Wu, Yusheng
    Wang, Mengxue
    Yi, Zhiying
    Li, Hongyuan
    Li, Hongzhong
    Ren, Guosheng
    JAMA NETWORK OPEN, 2020, 3 (01) : E1918160
12345